AwardedDNKGoodsFramework agreementDKK 136,000,000
Amgros 2026 1.163.a
- Published
- Published 18 March 2026
- Deadline
- Closed 27 April 2026
Overview
Amgros I/S, a joint venture owned by five Danish regions, awarded a framework agreement valued at 34 million DKK on 12 May 2026 for the supply of pharmaceuticals to hospital pharmacies across the regions and potentially to the Faroe Islands and Greenland. The contract was awarded to four suppliers: 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, and Roche Pharmaceuticals A/S under non-exclusive framework agreements without purchase obligations.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Estimated value
- DKK 136,000,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 18 March 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- DKK 34,000,000
- Award date
- 12 May 2026
- Contract period
- 1 November 2026 → 31 October 2028
- 2care4 ApS
- Abacus Medicine A/S
- Orifarm A/S
- Roche Pharmaceuticals A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
19 May 2026
Contract Notice
18 March 2026
Contracting authority
Amgros I/S
Procuring entityKøbenhavn Ø, DNK
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.